Risedronate prevents bone loss in breast cancer survivors: A two-year, randomized, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Greenspan, S. L. [1 ]
Vujevich, K. T. [1 ]
Bhattachary, R. [2 ]
Perera, S. [1 ]
Brufsky, A. [1 ]
Lembersky, B. C. [1 ]
Vogel, V. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Kansas, Kansas City, KS USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1017
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [11] Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial
    Hooper, MJ
    Ebeling, PR
    Roberts, AP
    Graham, JJ
    Nicholson, GC
    D'Emden, M
    Ernst, TF
    Wenderoth, D
    CLIMACTERIC, 2005, 8 (03) : 251 - 262
  • [12] Effects of Chicory and Fumitory on Hot Flashes Among Breast Cancer Survivors: A Randomized, Double-Blind Placebo-Controlled Trial
    Khosropanah, Alireza
    Mehri Ardestani, Mojgan
    Rostami, Nematollah
    Hashemi, Fatemeh
    Pasalar, Mehdi
    Hunter, Jennifer
    Heydarirad, Ghazaleh
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2023, 29 (01): : 31 - 41
  • [13] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, Eduardo
    El Osta, Badi
    Valero, Vicente
    Driver, Larry C.
    Pei, Be-Lian
    Shen, Loren
    Poulter, Valerie A.
    Palmer, J. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3475 - 3481
  • [14] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [15] Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients
    Ryan, Julie L.
    Heckler, Charles E.
    Ling, Marilyn
    Katz, Alan
    Williams, Jacqueline P.
    Pentland, Alice P.
    Morrow, Gary R.
    RADIATION RESEARCH, 2013, 180 (01) : 34 - 43
  • [16] Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial
    C. C. Mok
    K. H. Tong
    C. H. To
    Y. P. Siu
    K. M. Ma
    Osteoporosis International, 2008, 19 : 357 - 364
  • [17] Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial
    Mok, C. C.
    Tong, K. H.
    To, C. H.
    Siu, Y. P.
    Ma, K. M.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (03) : 357 - 364
  • [18] A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer
    Lubas, Margaret M.
    Mandrell, Belinda N.
    Greene, William L.
    Howell, Carrie R.
    Christensen, Robbin
    Kimberg, Cara I.
    Li, Chenghong
    Ness, Kirsten K.
    Srivastava, Deo Kumar
    Hudson, Melissa M.
    Robison, Leslie L.
    Krull, Kevin R.
    Brinkman, Tara M.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (01)
  • [19] A randomized, double-blind, placebo-controlled trial of methylphenidate for attentional problems in survivors of childhood cancer.
    Mulhern, RK
    Khan, R
    Kaplan, S
    Xiong, X
    Wu, S
    Helton, S
    Brown, R
    Bonner, M
    Christensen, R
    Reddick, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 801S - 801S
  • [20] A randomized, double-blind, placebo-controlled trial of ormeloxifene in breast pain and nodularity
    Kumar, Sandeep
    Rai, Ruchi
    Agarwal, G. G.
    Dwivedi, Varsha
    Kumar, Surender
    Das, Vinita
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (02): : 69 - 74
12345